Projects per year
- 100 - 124 out of 124 results
Search results
-
Completed
A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections
Aigbivbalu, L. (PI)
11/13/13 → 11/12/15
Project: Research project
-
A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination with Phototherapy in Neonates
Shattuck, K. (PI)
9/26/13 → 9/25/17
Project: Research project
-
Pharmacokinetics of Antistaphylococcal Antibiotics in Infants; HHSN- 2752010000031
Shattuck, K. (PI)
2/23/13 → 8/26/15
Project: Research project
-
Protocol No.: V503-003-00-0255: "A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillornavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year Old Men and 16- to 26-Year Old Women"
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
1/3/13 → 1/2/15
Project: Research project
-
Phase 1b, Partial-Blind, Parallel Group, Randomized Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine (DENVax) Administered Intradermally Using Needle or a Needle-Free PharmaJet Injector in Healthy Adults
Rupp, R. (PI)
Takeda Vaccines, Inc ( Award #HHSN272201000034C)
12/31/12 → 12/6/15
Project: Research project
-
-
Human Metapneumorivus M2-2 Protein Promotes Viral Evasion from Host Innate Immunity
Bao, X. (PI)
American Lung Association - New York ( Award #RG232529N)
7/1/12 → 6/30/15
Project: Research project
-
Protocol No.: V221-027; A Phase III Double-Blind, Randomized, Multicenter, Contgrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, Varicella (MMRV) Vaccine Made with Alternative Manufacturing Process (AMP)
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
6/21/12 → 6/20/14
Project: Research project
-
Protocol No.: V59P23; "A Phase 3b, Open Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants"
Rupp, R. (PI)
Novartis Vaccines and Diagnostics, Inc ( Award # )
4/27/12 → 4/26/14
Project: Research project
-
Protocol: V114-002-008, "A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of a Pneumococcal Conjugate Vaccine (V114) Compared to Pneumococcal Polysaccharide Vaccine (PNEUMOVAX 23) and Prevnar 13 (Pneumococcal 13-Valent
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
3/1/12 → 6/14/19
Project: Research project
-
Protocol Number: INV-DEN-104; A Randomized, Phase 1b Study to Investigate the Safety and Immunogenicty of Various Schedules of Tetravalent Chimeric Dengue Vaccine in Healthy Adult Volunteers Between the Ages of 18-45 Years
Rupp, R. (PI)
Takeda Vaccines, Inc ( Award # )
12/20/11 → 9/1/15
Project: Research project
-
The Role of Altered B7-homologue expression by ISEMFs in IBD
Reyes, V. E. (PI)
Crohn's and Colitis Foundation of America ( Award #2840)
7/1/10 → 6/30/14
Project: Research project
-
Innate Immune Response to Human Metapneumovirus Infection
Casola, A. (PI)
National Institute of Allergy and Infectious Diseases ( Award #5R01AI07924605)
6/1/10 → 5/31/17
Project: Research project
-
Early Childhood Intervention (93.558)
Richardson, J. (PI)
Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)
9/1/09 → 8/31/20
Project: Research project
-
Early Childhood Intervention (84.027)
Richardson, J. (PI)
Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)
9/1/09 → 8/31/20
Project: Research project
-
Early Childhood Intervention (84.393)
Richardson, J. (PI)
Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)
9/1/09 → 8/31/20
Project: Research project
-
Early Childhood Intervention - ARRA
Richardson, J. (PI)
Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)
9/1/09 → 8/31/20
Project: Research project
-
Early Childhood Intervention (Non ARRA)
Richardson, J. (PI)
Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)
9/1/09 → 8/31/20
Project: Research project
-
Early Childhood Intervention (84.181)
Richardson, J. (PI)
Texas Department of Assistive and Rehabilitative Services ( Award #53802C7059)
9/1/09 → 8/30/20
Project: Research project
-
Herpes Simplex Immunotherapeutic Vaccine
Bourne, N. (PI)
Vical, Inc ( Award #5R42AI06501503)
4/1/09 → 3/31/12
Project: Research project
-
Protocol No. V59P13E1: A Phase 3, Open-Label,Multi-Center Study to Evaluate the Persistence of Novartis MenACWY Antibody Response in Adolescents who Have Previously received either Novartis MenACWY Conjugate Vaccine or Menactra
Rupp, R. (PI)
Novartis Vaccines and Diagnostics, Inc ( Award #V59P13E1)
2/2/09 → 2/1/15
Project: Research project
-
Novartis V59P13: A Phase III, Randomized, Ovserver-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistency of Novartis Meningococcal ACWY Conjugate Vaccine when One Dose is Administered to Healthy Adolescents 11-18 Years of Age and t
Rupp, R. (PI)
Novartis Pharmaceuticals Corporation ( Award # )
2/10/07 → 3/31/15
Project: Research project
-
Testing 5 Compounds in the 1A Replicon System
Bourne, N. (PI)
Anadys Pharmaceuticals ( Award # )
6/1/06 → 2/26/12
Project: Research project